#78Regional leaders 1–100

Dechra Pharmaceuticals

United Kingdom · United Kingdom

Veterinary pharmaFinished dosage forms and small molecules

Manufacturing profile

Country
United Kingdom
Regulatory region
United Kingdom
ISO
GBR

Selection basis

The company is placed in positions 1–100 as a major regional manufacturer, biopharmaceutical group, important generics supplier or manufacturing/CDMO leader.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Biological or chemical starting materials
  2. 2Vaccine or API production
  3. 3Formulation and filling
  4. 4Potency, microbiology and impurity control
  5. 5Batch traceability and release
  6. 6Raw-material receipt and identification
  7. 7Dispensing, blending and granulation
  8. 8Tableting, encapsulation or solution preparation
  9. 9Packaging and labelling

Relevant FUZKK packages

Lumex — instrumental QC

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology